{"title":"一种新型丙二醇方案在减少过渡奶牛酮症中的有效性。","authors":"Yuxi Song, Xuejie Jiang, Yu Hao, Rui Sun, Yunlong Bai, Guang Shao, Wanxia Ren, Cheng Xia","doi":"10.3389/fvets.2025.1609300","DOIUrl":null,"url":null,"abstract":"<p><p>Ketosis is a prevalent metabolic disease in dairy cows, characterized by adverse effects on both animal health and production performance. Propylene glycol (PG), recognized for its glucogenic properties, is widely utilized in the therapeutic management of ketosis. This study evaluated the efficacy of two PG-based treatment protocols in mitigating ketosis and enhancing the metabolic health of <i>Holstein</i> cows. Ninety cows were randomly allocated into three groups (<i>n</i> = 30 each): control (Group C, no PG), original PG protocol (Group O, 500 mL PG orally drenched once daily on days 0, 1, 2, 7, 8, and 9 post-calving), and novel PG protocol (Group N, 500 mL PG orally drenched once daily on days 0, 7, and 14 post-calving). Data were collected for body condition score, milk yield, metabolic biomarkers, and the incidence of ketosis from 14 (±3) days prepartum to 50 days postpartum. The results demonstrated that the novel PG protocol, compared with the control group, significantly enhanced energy metabolism by modulating glucose, insulin, and leptin levels while reducing <i>β</i>-hydroxybutyric acid and non-esterified fatty acid concentrations (<i>p</i> < 0.05). Additionally, the novel PG protocol effectively decreased the incidence of ketosis (from 33.3% in Group C to 6.7% in Group N at 14 days postpartum), alleviated liver injury, and mitigated oxidative stress in dairy cows (<i>p</i> < 0.05). These findings underscore the potential of the novel PG protocol to improve metabolic health and reduce the risk of ketosis during the critical transition period in dairy cows. This offers a promising strategy for managing this condition in modern dairy production systems.</p>","PeriodicalId":12772,"journal":{"name":"Frontiers in Veterinary Science","volume":"12 ","pages":"1609300"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153510/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of a novel propylene glycol protocol in reducing ketosis in transition dairy cows.\",\"authors\":\"Yuxi Song, Xuejie Jiang, Yu Hao, Rui Sun, Yunlong Bai, Guang Shao, Wanxia Ren, Cheng Xia\",\"doi\":\"10.3389/fvets.2025.1609300\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ketosis is a prevalent metabolic disease in dairy cows, characterized by adverse effects on both animal health and production performance. Propylene glycol (PG), recognized for its glucogenic properties, is widely utilized in the therapeutic management of ketosis. This study evaluated the efficacy of two PG-based treatment protocols in mitigating ketosis and enhancing the metabolic health of <i>Holstein</i> cows. Ninety cows were randomly allocated into three groups (<i>n</i> = 30 each): control (Group C, no PG), original PG protocol (Group O, 500 mL PG orally drenched once daily on days 0, 1, 2, 7, 8, and 9 post-calving), and novel PG protocol (Group N, 500 mL PG orally drenched once daily on days 0, 7, and 14 post-calving). Data were collected for body condition score, milk yield, metabolic biomarkers, and the incidence of ketosis from 14 (±3) days prepartum to 50 days postpartum. The results demonstrated that the novel PG protocol, compared with the control group, significantly enhanced energy metabolism by modulating glucose, insulin, and leptin levels while reducing <i>β</i>-hydroxybutyric acid and non-esterified fatty acid concentrations (<i>p</i> < 0.05). Additionally, the novel PG protocol effectively decreased the incidence of ketosis (from 33.3% in Group C to 6.7% in Group N at 14 days postpartum), alleviated liver injury, and mitigated oxidative stress in dairy cows (<i>p</i> < 0.05). These findings underscore the potential of the novel PG protocol to improve metabolic health and reduce the risk of ketosis during the critical transition period in dairy cows. This offers a promising strategy for managing this condition in modern dairy production systems.</p>\",\"PeriodicalId\":12772,\"journal\":{\"name\":\"Frontiers in Veterinary Science\",\"volume\":\"12 \",\"pages\":\"1609300\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12153510/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Veterinary Science\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.3389/fvets.2025.1609300\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Veterinary Science","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.3389/fvets.2025.1609300","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
摘要
酮症是奶牛的一种普遍代谢性疾病,其特点是对动物健康和生产性能产生不利影响。丙二醇(PG)因其糖原特性而被广泛应用于酮症的治疗管理。本研究评估了两种以pg为基础的治疗方案在缓解荷斯坦奶牛酮症和促进代谢健康方面的效果。90头奶牛随机分为3组(每组n = 30头):对照组(C组,不含PG)、原PG方案组(O组,产犊后第0、1、2、7、8和9天每天口服一次500 mL PG)和新PG方案组(n组,产犊后第0、7和14天每天口服一次500 mL PG)。收集产前14(±3)天至产后50 天的身体状况评分、产奶量、代谢生物标志物和酮症发生率的数据。结果表明,与对照组相比,新型PG方案通过调节葡萄糖、胰岛素和瘦素水平,同时降低β-羟基丁酸和非酯化脂肪酸浓度,显著增强了能量代谢(p p
Effectiveness of a novel propylene glycol protocol in reducing ketosis in transition dairy cows.
Ketosis is a prevalent metabolic disease in dairy cows, characterized by adverse effects on both animal health and production performance. Propylene glycol (PG), recognized for its glucogenic properties, is widely utilized in the therapeutic management of ketosis. This study evaluated the efficacy of two PG-based treatment protocols in mitigating ketosis and enhancing the metabolic health of Holstein cows. Ninety cows were randomly allocated into three groups (n = 30 each): control (Group C, no PG), original PG protocol (Group O, 500 mL PG orally drenched once daily on days 0, 1, 2, 7, 8, and 9 post-calving), and novel PG protocol (Group N, 500 mL PG orally drenched once daily on days 0, 7, and 14 post-calving). Data were collected for body condition score, milk yield, metabolic biomarkers, and the incidence of ketosis from 14 (±3) days prepartum to 50 days postpartum. The results demonstrated that the novel PG protocol, compared with the control group, significantly enhanced energy metabolism by modulating glucose, insulin, and leptin levels while reducing β-hydroxybutyric acid and non-esterified fatty acid concentrations (p < 0.05). Additionally, the novel PG protocol effectively decreased the incidence of ketosis (from 33.3% in Group C to 6.7% in Group N at 14 days postpartum), alleviated liver injury, and mitigated oxidative stress in dairy cows (p < 0.05). These findings underscore the potential of the novel PG protocol to improve metabolic health and reduce the risk of ketosis during the critical transition period in dairy cows. This offers a promising strategy for managing this condition in modern dairy production systems.
期刊介绍:
Frontiers in Veterinary Science is a global, peer-reviewed, Open Access journal that bridges animal and human health, brings a comparative approach to medical and surgical challenges, and advances innovative biotechnology and therapy.
Veterinary research today is interdisciplinary, collaborative, and socially relevant, transforming how we understand and investigate animal health and disease. Fundamental research in emerging infectious diseases, predictive genomics, stem cell therapy, and translational modelling is grounded within the integrative social context of public and environmental health, wildlife conservation, novel biomarkers, societal well-being, and cutting-edge clinical practice and specialization. Frontiers in Veterinary Science brings a 21st-century approach—networked, collaborative, and Open Access—to communicate this progress and innovation to both the specialist and to the wider audience of readers in the field.
Frontiers in Veterinary Science publishes articles on outstanding discoveries across a wide spectrum of translational, foundational, and clinical research. The journal''s mission is to bring all relevant veterinary sciences together on a single platform with the goal of improving animal and human health.